These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18059262)

  • 1. An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission.
    Shirey JK; Xiang Z; Orton D; Brady AE; Johnson KA; Williams R; Ayala JE; Rodriguez AL; Wess J; Weaver D; Niswender CM; Conn PJ
    Nat Chem Biol; 2008 Jan; 4(1):42-50. PubMed ID: 18059262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
    Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
    Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the function of M4 muscarinic acetylcholine receptors gained using a novel allosteric modulator and a DREADD (designer receptor exclusively activated by a designer drug).
    Nawaratne V; Leach K; Suratman N; Loiacono RE; Felder CC; Armbruster BN; Roth BL; Sexton PM; Christopoulos A
    Mol Pharmacol; 2008 Oct; 74(4):1119-31. PubMed ID: 18628403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties.
    Leach K; Loiacono RE; Felder CC; McKinzie DL; Mogg A; Shaw DB; Sexton PM; Christopoulos A
    Neuropsychopharmacology; 2010 Mar; 35(4):855-69. PubMed ID: 19940843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning.
    Sheffler DJ; Williams R; Bridges TM; Xiang Z; Kane AS; Byun NE; Jadhav S; Mock MM; Zheng F; Lewis LM; Jones CK; Niswender CM; Weaver CD; Lindsley CW; Conn PJ
    Mol Pharmacol; 2009 Aug; 76(2):356-68. PubMed ID: 19407080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Parallel Multiparametric Cell-Based FLIPR Detection Assays for the Identification of Modulators of the Muscarinic Acetylcholine Receptor 4 (M4).
    Smith E; Chase P; Niswender CM; Utley TJ; Sheffler DJ; Noetzel MJ; Lamsal A; Wood MR; Conn PJ; Lindsley CW; Madoux F; Acosta M; Scampavia L; Spicer T; Hodder P
    J Biomol Screen; 2015 Aug; 20(7):858-68. PubMed ID: 25877150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing structural requirements of positive allosteric modulators of the M4 muscarinic receptor.
    Huynh T; Valant C; Crosby IT; Sexton PM; Christopoulos A; Capuano B
    J Med Chem; 2013 Oct; 56(20):8196-200. PubMed ID: 24074052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats.
    Jones CK; Brady AE; Davis AA; Xiang Z; Bubser M; Tantawy MN; Kane AS; Bridges TM; Kennedy JP; Bradley SR; Peterson TE; Ansari MS; Baldwin RM; Kessler RM; Deutch AY; Lah JJ; Levey AI; Lindsley CW; Conn PJ
    J Neurosci; 2008 Oct; 28(41):10422-33. PubMed ID: 18842902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of allosteric potentiators of the m(4) muscarinic acetylcholine receptor.
    Kennedy JP; Bridges TM; Gentry PR; Brogan JT; Kane AS; Jones CK; Brady AE; Shirey JK; Conn PJ; Lindsley CW
    ChemMedChem; 2009 Oct; 4(10):1600-7. PubMed ID: 19705385
    [No Abstract]   [Full Text] [Related]  

  • 10. Muscarinic Modulation of Synaptic Transmission and Short-Term Plasticity in the Dorsal and Ventral Hippocampus.
    Tsotsokou G; Trompoukis G; Papatheodoropoulos C
    Mol Cell Neurosci; 2024 Jun; 129():103935. PubMed ID: 38703973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of species variability and 'probe-dependence' on the detection and in vivo validation of allosteric modulation at the M4 muscarinic acetylcholine receptor.
    Suratman S; Leach K; Sexton P; Felder C; Loiacono R; Christopoulos A
    Br J Pharmacol; 2011 Apr; 162(7):1659-70. PubMed ID: 21198541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.
    Schrage R; Holze J; Klöckner J; Balkow A; Klause AS; Schmitz AL; De Amici M; Kostenis E; Tränkle C; Holzgrabe U; Mohr K
    Biochem Pharmacol; 2014 Aug; 90(3):307-19. PubMed ID: 24863257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.
    Threlfell S; Clements MA; Khodai T; Pienaar IS; Exley R; Wess J; Cragg SJ
    J Neurosci; 2010 Mar; 30(9):3398-408. PubMed ID: 20203199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic acetylcholine M
    Liu L; Huang Y; Huang Q; Zhao Z; Yu J; Wang L
    Neuropharmacology; 2017 May; 117():376-386. PubMed ID: 28257887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing functions of spinal M2, M3, and M4 receptor subtypes in regulation of GABAergic inputs to dorsal horn neurons revealed by muscarinic receptor knockout mice.
    Zhang HM; Chen SR; Matsui M; Gautam D; Wess J; Pan HL
    Mol Pharmacol; 2006 Mar; 69(3):1048-55. PubMed ID: 16365281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biased Profile of Xanomeline at the Recombinant Human M
    McDonald JK; van der Westhuizen ET; Pham V; Thompson G; Felder CC; Paul SM; Thal DM; Christopoulos A; Valant C
    ACS Chem Neurosci; 2022 Apr; 13(8):1206-1218. PubMed ID: 35380782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Synthesis of Clinical Candidate PF-06852231 (CVL-231): A Brain Penetrant, Selective, Positive Allosteric Modulator of the M
    Butler CR; Popiolek M; McAllister LA; LaChapelle EA; Kramer M; Beck EM; Mente S; Brodney MA; Brown M; Gilbert A; Helal C; Ogilvie K; Starr J; Uccello D; Grimwood S; Edgerton J; Garst-Orozco J; Kozak R; Lotarski S; Rossi A; Smith D; O'Connor R; Lazzaro J; Steppan C; Steyn SJ
    J Med Chem; 2024 Jul; 67(13):10831-10847. PubMed ID: 38888621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and Development of Muscarinic Acetylcholine M
    Takai K; Enomoto T
    Chem Pharm Bull (Tokyo); 2018; 66(1):37-44. PubMed ID: 29311510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive allosteric modulation of M
    Yohn SE; Conn PJ
    Neuropharmacology; 2018 Jul; 136(Pt C):438-448. PubMed ID: 28893562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric effects of four stereoisomers of a fused indole ring system with 3H-N-methylscopolamine and acetylcholine at M1-M4 muscarinic receptors.
    Lazareno S; Birdsall B; Fukazawa T; Gharagozloo P; Hashimoto T; Kuwano H; Popham A; Sugimoto M; Birdsall NJ
    Life Sci; 1999; 64(6-7):519-26. PubMed ID: 10069518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.